Bright Minds Biosciences Inc.
DRUG
Price:
$35.33
Market Cap:
$343.20M
Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.[Read more]
Industry
Biotechnology
IPO Date
2021-03-22
Stock Exchange
NASDAQ
Ticker
DRUG
PE Ratio
[-56.08]
ROE
[-58.51%]
Current Ratio
[35.08]
Dividend Yield
[0%]
Enterprise Value
[337.02M]
Dividend History
The ROE as of November 2024 (TTM) for Bright Minds Biosciences Inc. (DRUG) is -58.51%
According to Bright Minds Biosciences Inc.’s latest financial reports and current stock price. The company's current ROE is -58.51%. This represents a change of 305.97% compared to the average of -14.41% of the last 4 quarters.
Bright Minds Biosciences Inc. (DRUG) Historical ROE (quarterly & annually)
How has DRUG ROE performed in the past?
The mean historical ROE of Bright Minds Biosciences Inc. over the last ten years is -85.63%. The current -58.51% ROE has changed -31.67% with respect to the historical average. Over the past ten years (40 quarters), DRUG's ROE was at its highest in in the June 2024 quarter at 3.52%. The ROE was at its lowest in in the December 2019 quarter at -69.37%.
Average
-85.63%
Median
-66.63%
Minimum
-144.06%
Maximum
-43.89%
Bright Minds Biosciences Inc. (DRUG) ROE by Quarter and Year
Discovering the peaks and valleys of Bright Minds Biosciences Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 228.24%
Maximum Annual ROE = -43.89%
Minimum Annual Increase = -34.13%
Minimum Annual ROE = -144.06%
| Year | ROE | Change |
|---|---|---|
| 2023 | -111.73% | -22.44% |
| 2022 | -144.06% | 228.24% |
| 2021 | -43.89% | -34.13% |
| 2020 | -66.63% | 7.72% |
Bright Minds Biosciences Inc. (DRUG) Average ROE
How has DRUG ROE performed in the past?
The current ROE of Bright Minds Biosciences Inc. (DRUG) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-99.89%
5-year avg
-85.63%
10-year avg
-85.63%
Bright Minds Biosciences Inc. (DRUG) ROE vs. Peers
How is DRUG’s ROE compared to its peers?
Bright Minds Biosciences Inc.’s ROE is greater than Revelation Biosciences, Inc. (-311.33%), greater than Zura Bio Limited (-39.61%), greater than Phio Pharmaceuticals Corp. (-134.57%), greater than ZyVersa Therapeutics, Inc. (-25512.50%), greater than TransCode Therapeutics, Inc. (-649.01%), greater than Pyxis Oncology, Inc. (-36.23%), less than eFFECTOR Therapeutics, Inc. (2.18%), less than Altamira Therapeutics Ltd. (783.37%), greater than Elevation Oncology, Inc. (-59.73%), less than Apexigen, Inc. (48.27%), greater than Immix Biopharma, Inc. (-102.10%), greater than Virios Therapeutics, Inc. (-130.35%), greater than Navidea Biopharmaceuticals, Inc. (-173.56%), greater than Aditxt, Inc. (-431.38%), greater than NeuroBo Pharmaceuticals, Inc. (-189.12%), greater than Dermata Therapeutics, Inc. (-247.40%), greater than Unicycive Therapeutics, Inc. (-374.14%),
| Company | ROE | Market cap |
|---|---|---|
| -311.33% | $3.24M | |
| -39.61% | $178.25M | |
| -134.57% | $2.61M | |
| -25512.50% | $2.65M | |
| -649.01% | $6.64M | |
| -36.23% | $112.90M | |
| 2.18% | $941.00 | |
| 783.37% | $1.60M | |
| -59.73% | $35.67M | |
| 48.27% | $9.57M | |
| -102.10% | $49.14M | |
| -130.35% | $206.50K | |
| -173.56% | $100.08K | |
| -431.38% | $4.82M | |
| -189.12% | $20.42M | |
| -247.40% | $2.32M | |
| -374.14% | $55.01M |
Build a custom stock screener for Bright Minds Biosciences Inc. (DRUG) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bright Minds Biosciences Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Bright Minds Biosciences Inc. (DRUG) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Bright Minds Biosciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Bright Minds Biosciences Inc.'s ROE?
How is the ROE calculated for Bright Minds Biosciences Inc. (DRUG)?
What is the highest ROE for Bright Minds Biosciences Inc. (DRUG)?
What is the 3-year average ROE for Bright Minds Biosciences Inc. (DRUG)?
What is the 5-year average ROE for Bright Minds Biosciences Inc. (DRUG)?
How does the current ROE for Bright Minds Biosciences Inc. (DRUG) compare to its historical average?